期刊文献+

钙化性主动脉瓣狭窄病理机制及治疗进展 被引量:3

Pathogenesis and treatment of calcific aortic valve stenosis
下载PDF
导出
摘要 主动脉瓣狭窄是临床上比较常见的心脏瓣膜病,其主要的病因是主动脉瓣膜钙化。随着人口老龄化的加剧,钙化性主动脉瓣膜病的发病率也不断的增加,因此,过去20多年中,钙化性主动脉瓣膜狭窄一直被认为是一种退行性病变,然而随着近年的研究进展,大量的证据表明,钙化性主动脉瓣膜病是一个活跃的病理过程,其与动脉粥样硬化有相同的风险因素和病理生理特点。本文主要对近年来钙化性主动脉瓣膜病发病机制及治疗进展的研究做一综述。 Aortic stenosis is clinically more common valvular heart disease, and the main cause is aortic valve calcification. With the increase in aging of the population, caleific aortic valve disease incidence also increased continuously. Therefore, during the past 20 years, ealcific aortic valve stenosis has been considered as a degenerative disease, but with research progress in recent years, a large amount of evidence indicates that ealcifie aortic valve disease is an active disease process similar to that of athero- sclerosis with the same risk factors and pathophysiologieal features. This paper summarizes the main research on the progression of the pathogenesis of calcific aortic valve disease and treatment in recent years.
作者 叶挺 宗刚军
出处 《心脏杂志》 CAS 2016年第3期366-369,共4页 Chinese Heart Journal
基金 国家自然科学基金项目资助(81371657)
关键词 主动脉瓣狭窄 心脏瓣膜病 钙化性主动脉瓣膜病 发病机理与治疗 aortic valve stenosis heart valve disease caleific aortic valve disease pathogenesis and treatment
  • 相关文献

参考文献27

  • 1Maganti K, Rigolin VH, Sarano ME, et al. Valvular heart disease: diagnosis and management[J]. Mayo Clin Proc, 2010, 85(5) :483 -500.
  • 2Supino PG, Borer JS, Preibisz J, et al. The epidemiology of valvu- lar heart disease: a growing public health problem [ J ]. Heart Fail Clin, 2006, 2(4):379-393.
  • 3Rajamannan NM, Evans FJ, Aikawa E, et al. Calcifi aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcifi aortic valve disease-2011 update [ J ]. Circulation, 2011, 124 (16) : 1783 - 1791.
  • 4Tobin JR Jr, Rahimtoola SH, Blundell PE, et al. Percentage of left ventricular stroke work loss. A simple hemodynamic concept for esti- mation of severity in valvular aortic stenosis[J]. Circulation, 1967, 35(5) :868 -879.
  • 5Nassimiha D, Aronow WS, Ahn C, et ul. Rate of progression of valvular aortic stenosis in patients > or : 60 years of age [ J ]. Am J Cardiol, 2001, 87(6) :807 -809, A9.
  • 6Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Man- agement of Valvular Hearth Disease of the European Society of Car- diology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease : The Task Force on the Man- agement of valvular heart disease of the European Society of Cardiol- ogy[J]. Ear Heart J, 2007, 28(2) :230 -268.
  • 7Vahanian A, Alfiri O, Andreotti F, et al. Guidelines on the man- agement of valvular heart disease ( version 2012 ) : the Joint Task Force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Car- dio-Thoracic Surgery (EACTS) [ J ]. Eur J Cardiothorac Surg, 2012, 42(4) :S1 -S44.
  • 8Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology [ J ]. Am J Pathol, 2007, 171(5) :1407 -1418.
  • 9Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of‘ degenerative' valvular aortic stenosis. Histologi- cal and immunohistochemical studies [J]. Circulation, 1994, 90 (2) :844 -853.
  • 10Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associat- ed with calcify aortic valve disease. Cardiovascular Health Study [J]. JAm Coll Cardiol, 1997, 29(3) :630 -634.

同被引文献32

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部